Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 2/3 2Phase 2 2Phase 1/2 2Phase 3 1

Status

Unknown 2Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 33Carcinoma, Hepatocellular 27Neoplasms 19Colorectal Neoplasms 18Carcinoma, Non-Small-Cell Lung 16Stomach Neoplasms 15Leukemia, Myeloid, Acute 15Prostatic Neoplasms 12Lung Neoplasms 12Colonic Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Rectal Neoplasms 10Neoplasm Metastasis 8Leukemia 8Pancreatic Neoplasms 7NSCLC 6Multiple Myeloma 6Liver Neoplasms 6Esophageal Neoplasms 6Glioblastoma 5Small Cell Lung Carcinoma 4Recurrence 4Polycystic Ovary Syndrome 4Nasopharyngeal Carcinoma 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Head and Neck Neoplasms 4Gestational Trophoblastic Disease 4Esophageal Squamous Cell Carcinoma 4Cholangiocarcinoma 4

Interventions

COVID-19 Serotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × COVID-19 × Clear all
NCT04873414 2021-06-02

PlaSenTer

National Institute of Health Research and Development, Ministry of Health Republic of Indonesia

Phase 2/3 Unknown
364 enrolled
Lymphoid

COVID-19, Lymphoma, Follicular

NCT04384588 2020-05-12

FALP-COVID

Fundacion Arturo Lopez Perez

Phase 2/3 Unknown
100 enrolled

COVID-19

Data powered by HemOnc (CC BY 4.0) Colophon âš¡